• Case report: a brief description of a single case that an observer thinks should be brought to colleagues' attention • Case series: several case reports of similar observations, procedures, etc, that can be grouped together • Simple to perform; report usually can be written up and published rapidly • Often first form of reporting for new diseases or rare complications • Very limited in discerning cause-effect relationship or comparison of treatment effects (unless procedure is dramatic [eg, first successful dialysis])
Incidence/Prevalence Studies
• Determines magnitude of disease or a disease characteristic in population • Very important for planning resource utilization • Usually cross-sectional (prevalence) or longitudinal (incidence) design 
ANALYTIC STUDIES
Analytic studies are a more commonly encountered category of studies, involving comparisons between 2 or more groups. They are based on a research question and are etiologic, diagnostic, prognostic, therapeutic, and so on. Based on research architecture, the studies can be observational or experimental.
Observational Studies
In observational studies, exposure is not determined by the investigator.
Cross-sectional studies
• No longitudinal component (Fig 2) • Data on exposure and outcome assessed at same time • Strength: no waiting (fast and inexpensive) Retrospective cohort design.
• Much less time-consuming and costly compared with prospective cohort studies • Limited control over sampling of cohort and quality of predictor variables (collected in past)
Propensity score methodology.
• Improves causal inference in observational studies when compared groups are different at baseline with respect to intervention (exposure) • Propensity score is model-based predicted probability of receiving intervention (exposure) Ⅲ Cannot evaluate incidence/prevalence Ⅲ Only 1 outcome usually studied Ⅲ Limited control over quality of predictor variables Ⅲ Increased susceptibility to bias: sampling bias (selection of controls from unrelated population), recall bias (smoking or alcohol intake history) • Nested case-control design:
Ⅲ Case-control study embedded within cohort study Ⅲ Particularly useful design for predictors (eg, biomarkers) that are expensive to measure in whole cohort Ⅲ Preserves advantages of cohort studies (ie, cases and controls are from same population and predictors are measured before outcomes) Ⅲ For biomarker studies, samples need to be stored until outcomes occur for diagnostic studies • A properly planned and executed randomized clinical trial is powerful experimental technique for assessing effectiveness of an intervention • Randomized, double-blind, placebo-controlled trial ( 
Examples of case-control studies

Appendix. Glossary of Commonly Used Terms in Patient-Oriented Research
Absolute risk reduction (ARR): Mathematical difference in event rates for 2 groups, usually treatment and control. Alpha (type I) error: Error in hypothesis testing when a statistically significant association is found, but no "true" association exists (ie, rejecting the null hypothesis when it is true). The alpha error level is the threshold of statistical significance established by the researcher (P Ͻ 0.05 by convention). Beta (type II) error: Error in hypothesis testing when no statistically significant association is found, but a "true" association exists (ie, rejecting an alternative hypothesis when it is true). The beta error level is usually set at 0.2 or less. Bias: Systematic error in the design or conduct of a study, which threatens the validity of a study. Blinding: Element of study design in which patients and/or investigators do not know who is in the treatment group and who is in the control group; the term masking is often used.
Confidence interval (CI):
Describes the variability in a point estimate (relative risk, odds ratio, etc); usually reported as a 95% CI (ie, the range of values within which a 95% probability exists for true value). Confounding: A variable having independent associations with both the dependent and independent variables, potentially distorting their relationship. Effect size: The magnitude of a difference considered clinically meaningful. Used in power analysis to determine the required sample size. Effectiveness: A measure of the benefit resulting from an intervention for a given health problem under typical conditions of use; this form of evaluation considers both the efficacy of an intervention and its acceptance by those to whom it is offered, providing an answer to the following question: Does the practice do more good than harm to people to whom it is offered? Efficacy: A measure of the benefit resulting from an intervention for a given health problem under ideal conditions of use; it answers the question: Does the practice do more good than harm to people who comply fully with the recommendations? Hypothesis: A formal statement, with statistical implications, that will be accepted or rejected based on the evidence (data collected) in a study. Incidence: Proportion of new cases of a specific condition in the population at risk during a specified time. Independent events: Events whose occurrence has no effect on the probability of each other. Independent variable: Variable associated with the outcome of interest that contributes information about the outcome in addition to that provided by other variables considered simultaneously. Intention-to-treat analysis: Method of analysis in randomized clinical trials in which all patients randomly assigned to a treatment group are analyzed in that treatment group, whether or not they received that treatment or completed the study. Interaction: Relationship between 2 independent variables, such that the effect of 1 variable on the outcome depends on the "level" of the other variable.
Likelihood ratio (LR):
Likelihood that a given test result would be expected in a patient with a condition compared to a patient without the condition. Ratio of true-positive rate to false-positive rate. Matching: Process of making 2 groups homogeneous regarding possible confounding factors. Meta-analysis: An evidence-based systematic review that uses quantitative methods to combine the results of several independent studies to produce summary statistics. Multiple comparisons: Pairwise group comparisons involving more than 1 P value. Negative predictive value (NPV): Probability of not having the disease given a negative diagnostic test; requires an estimate of prevalence. Null hypothesis: Default statistical hypothesis assuming no difference between groups; a "straw-man" statement that the data will (hopefully) refute. Number needed to treat (NNT): Number of persons who must be treated for a given period to achieve an event (treatment) or to prevent an event (prophylaxis). The NNT is the reciprocal of the absolute risk reduction. Odds: Probability that event will occur divided by probability that event will not occur. Odds ratio (OR): Ratio of the odds of having condition/outcome in experimental group to the odds of having the condition/ outcome in the control group; an estimate of relative risk obtained in case-control studies. One-tailed test: Test in which the alternative hypothesis specifies a deviation from the null hypothesis in 1 direction only; eg, treatment can be better (only) than placebo. Placebo: Inactive substance used to reduce bias by simulating the treatment under investigation.
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